The Imaging Dementia – Evidence for Amyloid Scanning (IDEAS) study is now accepting registrations from dementia specialists and PET imaging centers looking to participate in the research.

Marshfield Clinic Health System in Wisconsin has acquired technology that, it says, will make it the world’s first provider of mobile molecular breast imaging (MBI) services.

Radiological researchers in India have shown that a fully automated volumetric method can reliably provide accurate quantification of breast density.

Seno Medical Instruments, Inc. (Seno), the company pioneering the development of opto-acoustic technology as a new tool to improve the process of diagnosing breast cancer, announced today the presentation of case reports from the company's European MAESTRO Study, demonstrating the potential of its Imagio® opto-acoustic (OA) breast imaging system to provide physicians with vital information needed to determine whether a suspicious breast mass is cancerous or not, helping women avoid negative biopsy procedures.

Intelerad Medical Systems™, a leader in distributed medical imaging solutions, today announced a partnership to integrate Kailo Medical’s SonoReview solution with Intelerad’s product suite. 

A retrospective study of nearly three quarters of a million women in Germany shows that, as women age, their chances rise for having ductal carcinoma in situ (DCIS) detected in screening. 

One of the top stories to catch my eye this week has triggered a discussion on whether recommendations for screening should be adjusted. And it has nothing to do with mammography.

Stanford University researchers have developed a molecular tracer capable of locating and subsequently following a cancer-elevated protein in hard-to-find brain tumors.